Hologic (HOLX) Stock

HOLX will showcase groundbreaking innovations at this year's RSNA, concentrating on imaging technologies and artificial intelligence.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #3Dmammogram--Hologic welcomes participants to explore advancements in breast health and artificial intelligence at RSNA 2024.

Hologic (HOLX) has been getting a lot of interest from users on Zacks.com recently. Because of this, it's important to understand the factors that could affect the stock's future.

Hologic (HOLX) has been getting a lot of interest from users on Zacks.com recently. As a result, it's important to understand the factors that could affect the stock's future.

Even though Hologic recently reported lower earnings than expected, its strong product range and smart investment strategy may still attract investors.

HOLX's results for the fourth quarter of fiscal 2024 highlight the strong and lasting growth of its operations.

Hologic, Inc. (NASDAQ:HOLX) will hold its Q4 2024 Earnings Conference Call on November 4, 2024, at 4:30 PM ET. The call will feature key company leaders, including Ryan Simon, Stephen MacMillan, Essex Mitchell, and Karleen Oberton. Various analysts from different firms will also participate in the discussion.

The financial results for Hologic (HOLX) provide an overview of the company's performance for the quarter that ended in September 2024. It may be helpful to compare some important metrics with Wall Street predictions and figures from the same period last year.

Hologic (HOLX) reported quarterly earnings of $1.01 per share, which is slightly below the Zacks Consensus Estimate of $1.02 per share. This is an increase compared to earnings of $0.89 per share from the same period last year.